Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes - Wikidata - wikimedia - TriplyDB

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

http://www.wikidata.org/entity/Q35994803

about

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review The potential of mesenchymal stem cells in the management of radiation enteropathy Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells Inflection points in sepsis biology: from local defense to systemic organ injury Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy Dynamic Imaging of Marrow-Resident Granulocytes Interacting with Human Mesenchymal Stem Cells upon Systemic Lipopolysaccharide Challenge.Adipose-derived mesenchymal stem cells modulate CD14++CD16+ expression on monocytes from sepsis patients in vitro via prostaglandin E2.Concise Review: Mesenchymal Stromal Cell-Based Approaches for the Treatment of Acute Respiratory Distress and Sepsis Syndromes.Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats.Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep.An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions.Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy.An obligatory role of NF-κB in mediating bone marrow derived endothelial progenitor cell recruitment and proliferation following endotoxemic multiple organ injury in mice.An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.Therapeutic interventions in sepsis: current and anticipated pharmacological agents Harnessing the beneficial properties of adipogenic microbes for improving human health.Design and implementation of the START (STem cells for ARDS Treatment) trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome Human mesenchymal stem cells reduce the severity of acute lung injury in a sheep model of bacterial pneumonia.Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial.Human CD34+ progenitor cells freshly isolated from umbilical cord blood attenuate inflammatory lung injury following LPS challenge.Mesenchymal stem cells correct inappropriate epithelial-mesenchyme relation in pulmonary fibrosis using stanniocalcin-1.Mesenchymal stem cells as a therapeutic tool to treat sepsis.Endothelial FoxM1 mediates bone marrow progenitor cell-induced vascular repair and resolution of inflammation following inflammatory lung injury.Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis Preclinical Studies of Mesenchymal Stem Cell (MSC) Administration in Chronic Obstructive Pulmonary Disease (COPD): A Systematic Review and Meta-Analysis.In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome.Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.Coming to terms with tissue engineering and regenerative medicine in the lung.Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis.Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin.Expanded endothelial progenitor cells mitigate lung injury in septic mice.Role of epithelial sodium channels in the regulation of lung fluid homeostasis Human oral mucosa and gingiva: a unique reservoir for mesenchymal stem cells.Autophagy promotes apoptosis of mesenchymal stem cells under inflammatory microenvironment.Impact of apoptotic adipose-derived mesenchymal stem cells on attenuating organ damage and reducing mortality in rat sepsis syndrome induced by cecal puncture and ligation.

P2860

Q26773048-97F8E580-CC9A-4A7B-AD28-4D35A4F96C67 Q26801540-847AB591-B819-4871-AEC1-4AF73B4295FE Q27026350-3E37F1BE-EAB3-400E-8E40-E2F6F910A736 Q27692695-FE99928B-B42E-4A2A-9FDB-B3512C2A7DDB Q28587757-324DC67B-1F33-4997-8CF3-E80CFEB4A5D8 Q29994669-C3CF29B3-A152-4028-8E2E-7E61D6FF57A2 Q30538835-CE101AB9-6C73-4C7A-93F8-F7A1CD8F86D8 Q33608585-2922AF73-3748-4039-B752-2D1F1F437E23 Q33722631-EEF634A6-7077-47D9-B2C7-12EB1B04174D Q33745996-64ED3D92-957A-43D2-A6EE-63EF8ED5B578 Q33746517-AE7541F5-8679-484F-966A-DB11E1798865 Q33783282-C2864518-F501-448F-8D4B-21640BC33D72 Q33996870-CFC8151C-EFCE-4D7B-82FF-309B4A4D7B15 Q34131746-C3F0D1FC-A2EC-43CB-B9B0-DB27BE077DBC Q34380706-BA6A414F-5715-4226-B328-F4156385162D Q34387727-E27F3556-D2E0-4AC3-975C-5E5F47E7052A Q34427050-B91770EB-6A0F-4974-9844-7FD7CAA29AD4 Q34714843-1E30A04B-E2FF-4BC9-85BC-7B0510280091 Q34756148-E7C91955-407F-42F1-9D47-E99FEE4F9082 Q34824071-14E3E9A4-100C-4948-B186-F0639B9ABEAB Q34979725-05B8D646-858E-4E94-9053-08A76F6DD670 Q35099703-035E6F88-794C-414A-A2B4-09C5D4EEF10D Q35153085-E5E75777-DE06-4AFA-9794-CB267EB87B80 Q35205670-52230C68-7177-47AC-8B2B-5C7B926876A7 Q35252609-0B2CC2F4-06C8-4D0C-9D3B-B34178F6763D Q35555569-927EE24A-E371-483A-9E98-83D542C73B47 Q35604449-4D868C4B-1ACB-444D-A9B9-2F440A79A686 Q35809674-76EFCC34-C2D9-47F5-80BA-5C08D084A494 Q36035220-9227E007-EE74-486D-BC62-012559D81C79 Q36046310-53FE5543-33CE-4D13-B6AA-2253D47370FC Q36067836-762C1760-89B7-460B-B2D7-2AF47F97DA12 Q36096318-CAC446D8-9F2D-454B-A4B5-F9A775C02945 Q36122885-D735ABEB-82F1-49C0-8D13-7A167B96CD96 Q36172222-06C0E7A5-8B1A-4500-8315-98B999EE797E Q36212648-3F88D7B8-6247-4CA6-81F0-3A60EC81E750 Q36322012-BF0B5809-1D94-48DC-AF76-C2D3F9706DF3 Q36345877-E048C653-DE9A-49E5-AA16-64221260FF83 Q36375068-99524BAB-120D-42C2-8B63-57145CDC9A97 Q36376834-D89E66A9-0791-4B0E-8B72-F85808D83EBD Q36527041-9FCDFA1F-2A8F-4D99-86D9-9F7FE66BBCA3

P2860

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes

http://www.wikidata.org/entity/Q35994803

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@ast

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@en

type

label

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@ast

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@en

prefLabel

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@ast

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@en

P1433

Q35994803-84E00906-2F21-4892-B9A9-3C13EF1BEC7A

P1476

Q35994803-8BB8E9E5-5FAE-43E1-B435-0715E82B6C11

P2093

Q35994803-07D72214-F5E2-438F-AA71-9B5C87F5970B

Q35994803-0ADAA8A2-8C95-480B-8730-1DC64703B8E0

Q35994803-3F91A6CF-5507-4515-B0CD-87E641ED47F6

Q35994803-E2E70047-9633-42B2-B6AE-8D27CA8315C2

Q35994803-E7BA25E9-B8B7-4D1E-BD78-11FB8872DFAE

Q35994803-F2A10442-81B2-4A43-BBD5-504C925E4DDE

Q35994803-FB9B3277-68AD-4BF2-A185-A3F1364D589B

P2860

Q35994803-072D9F68-B306-4790-96D0-C64B0B56C385

Q35994803-10E06C83-6306-44FF-A0E5-2F77E36126DB

Q35994803-169EF560-9028-4C8E-9878-A77D4966B241

Q35994803-26CFB068-FDF7-4773-8C90-E1C6C71233FC

Q35994803-29137BC0-562A-45CF-9FF8-5E9D60ACCC8D

Q35994803-34DFB8E5-C756-4E5A-BB80-A74B8B2F38F7

Q35994803-414F3BFA-0432-4603-A0A0-66BB91595A7D

Q35994803-45949F75-1E9D-4869-BF2C-BBE46BEC5D4D

Q35994803-4CBA7EF1-CFFE-4BAC-9328-428FEFB444D0

Q35994803-4CEC6000-3BC1-4CB5-8CCF-C4D50ACA17E4

P304

Q35994803-B786650D-9BC9-4C28-8A86-4F63C7E32503

P31

Q35994803-7CE8E18E-836E-4B2D-A95F-B79A525B93F0

P356

Q35994803-D8D91AAB-CF14-4866-A5EB-CCA632B45E8B

P433

Q35994803-B7CBEB58-8419-4573-8DBA-D5C1E2EEC959

P478

Q35994803-B3EBE22D-A941-46D9-9F43-36C666FEAC95

P50

Q35994803-058149B5-B64D-4C36-B6CE-54C0BCAF09B5

Q35994803-A719D9CE-AE0F-423E-ADA9-82688F1583CB

P577

Q35994803-473C5AA1-A2DB-42C1-B609-3689F9278182

P5875

Q35994803-EC56228A-5EC2-477B-BDEE-96BC24CD814C

P698

Q35994803-88F3AF79-7B1C-430A-9B60-9F8FDD2BE93C

P921

Q35994803-6080520E-804D-4549-AD08-8512F3B98F5E

Q35994803-6AF7F318-8AA9-4349-92BF-B13EA0B9EF36

P932

Q35994803-A2742F19-E260-4102-BB72-A7D5291F3F0B

P356

AJPLUNG.00180.2011

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Human mesenchymal stem cells r ...... ic activity of blood monocytes

@en

P2093

Gianluca Samarani

http://www.w3.org/2001/XMLSchema#string

Hanjing Zhuo

http://www.w3.org/2001/XMLSchema#string

Jae-Woo Lee

http://www.w3.org/2001/XMLSchema#string

Mario Petrini

http://www.w3.org/2001/XMLSchema#string

Naveen Gupta

http://www.w3.org/2001/XMLSchema#string

Xiao Su

http://www.w3.org/2001/XMLSchema#string

Yuanlin Song

http://www.w3.org/2001/XMLSchema#string

P2860

Human multipotent stromal cells attenuate lipopolysaccharide-induced acute lung injury in mice via secretion of tumor necrosis factor-α-induced protein 6

Identification of splenic reservoir monocytes and their deployment to inflammatory sites

Multilineage potential of adult human mesenchymal stem cells

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

Complement-induced impairment of innate immunity during sepsis

Marrow stromal cells as stem cells for nonhematopoietic tissues

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta.

P304

L1003-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00180.2011

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

302

http://www.w3.org/2001/XMLSchema#string

P50

A Krasnodembskaya

Michael Matthay

P577

2012-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221715940

http://www.w3.org/2001/XMLSchema#string

P698

22427530

http://www.w3.org/2001/XMLSchema#string

P921

Gram-negative bacteria

P932

3362255

http://www.w3.org/2001/XMLSchema#string